[Chemotherapy of the elderly patients with advanced non-small cell lung cancer].
Chemotherapy of the elderly patients with III B/IV stage non-small cell lung cancer till remains controversial. We retrospectively reviewed the recent literatures, and conclude that single-agent chemotherapy should be the standard therapy of the elderly patients with IIIB/IV stage non-small cell lung cancer.
Cheng
Zhong-wei
ZW
Department of Internal Medicine, PUMC Hospital, CAMS and PUMC, Beijing 100730, China. czw15@hotmail.com
Zhang
Li
L
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000473:pathology; D002945:Cisplatin / Q000008:administration & dosage; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000077143:Docetaxel; D004334:Drug Administration Schedule; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D009367:Neoplasm Staging; D012189:Retrospective Studies; D015398:Signal Transduction / Q000187:drug effects; D043823:Taxoids / Q000008:administration & dosage; D000093542:Gemcitabine
D043823:Taxoids; D003841:Deoxycytidine; D000077143:Docetaxel; D005047:Etoposide; D002945:Cisplatin; D000093542:Gemcitabine